TCL Archive Pooled Analysis of Two LUX-Lung Trials Shows Prolonged Survival with Afatinib June 27, 2014
TCL Archive Phase III Alimta Trial Fails To Extend Progression-Free Survival Without Grade 4 Adverse Events June 28, 2013